Cargando…

MRI Radiomics and Machine Learning for the Prediction of Oncotype Dx Recurrence Score in Invasive Breast Cancer

SIMPLE SUMMARY: The preoperative definition of the Oncotype DX recurrence score would be critical to identify breast cancer patients who could benefit from chemotherapy before surgery. In this work, we built a machine learning model applied to DCE-MRI images of a publicly available dataset to predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Romeo, Valeria, Cuocolo, Renato, Sanduzzi, Luca, Carpentiero, Vincenzo, Caruso, Martina, Lama, Beatrice, Garifalos, Dimitri, Stanzione, Arnaldo, Maurea, Simone, Brunetti, Arturo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047199/
https://www.ncbi.nlm.nih.gov/pubmed/36980724
http://dx.doi.org/10.3390/cancers15061840
_version_ 1785013860893196288
author Romeo, Valeria
Cuocolo, Renato
Sanduzzi, Luca
Carpentiero, Vincenzo
Caruso, Martina
Lama, Beatrice
Garifalos, Dimitri
Stanzione, Arnaldo
Maurea, Simone
Brunetti, Arturo
author_facet Romeo, Valeria
Cuocolo, Renato
Sanduzzi, Luca
Carpentiero, Vincenzo
Caruso, Martina
Lama, Beatrice
Garifalos, Dimitri
Stanzione, Arnaldo
Maurea, Simone
Brunetti, Arturo
author_sort Romeo, Valeria
collection PubMed
description SIMPLE SUMMARY: The preoperative definition of the Oncotype DX recurrence score would be critical to identify breast cancer patients who could benefit from chemotherapy before surgery. In this work, we built a machine learning model applied to DCE-MRI images of a publicly available dataset to predict the Oncotype DX score in patients with breast cancer. As a result, the model achieved an accuracy of 60% in the training set and 63% (AUC = 0.66) in the test set. Our findings support the feasibility of radiomics and machine learning for the prediction of prognostic data in breast cancer, encouraging further, preferably multicenter, investigations to further improve the performance of the model and assess its generalizability. ABSTRACT: Aim: To non-invasively predict Oncotype DX recurrence scores (ODXRS) in patients with ER+ HER2- invasive breast cancer (IBC) using dynamic contrast-enhanced (DCE) MRI-derived radiomics features extracted from primary tumor lesions and a ML algorithm. Materials and Methods: Pre-operative DCE-MRI of patients with IBC, no history of neoadjuvant therapy prior to MRI, and for which the ODXRS was available, were retrospectively selected from a public dataset. ODXRS was obtained on histological tumor samples and considered as positive if greater than 16 and 26 in patients aged under and over 50 years, respectively. Tumor lesions were manually annotated by three independent operators on DCE-MRI images through 3D ROIs positioning. Radiomic features were therefore extracted and selected using multistep feature selection process. A logistic regression ML classifier was then employed for the prediction of ODXRS. Results: 248 patients were included, of which 87 with positive ODXRS. 166 (66%) patients were grouped in the training set, while 82 (33%) in the test set. A total of 1288 features was extracted. Of these, 1244 were excluded as 771, 82 and 391 were excluded as not stable (n = 771), not variant (n = 82), and highly intercorrelated (n = 391), respectively. After the use of recursive feature elimination with logistic regression estimator and polynomial transformation, 92 features were finally selected. In the training set, the logistic regression classifier obtained an overall mean accuracy of 60%. In the test set, the accuracy of the ML classifier was 63%, with a sensitivity of 80%, specificity of 43%, and AUC of 66%. Conclusions: Radiomics and ML applied to pre-operative DCE-MRI in patients with IBC showed promises for the non-invasive prediction of ODXRS, aiding in selecting patients who will benefit from NAC.
format Online
Article
Text
id pubmed-10047199
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100471992023-03-29 MRI Radiomics and Machine Learning for the Prediction of Oncotype Dx Recurrence Score in Invasive Breast Cancer Romeo, Valeria Cuocolo, Renato Sanduzzi, Luca Carpentiero, Vincenzo Caruso, Martina Lama, Beatrice Garifalos, Dimitri Stanzione, Arnaldo Maurea, Simone Brunetti, Arturo Cancers (Basel) Article SIMPLE SUMMARY: The preoperative definition of the Oncotype DX recurrence score would be critical to identify breast cancer patients who could benefit from chemotherapy before surgery. In this work, we built a machine learning model applied to DCE-MRI images of a publicly available dataset to predict the Oncotype DX score in patients with breast cancer. As a result, the model achieved an accuracy of 60% in the training set and 63% (AUC = 0.66) in the test set. Our findings support the feasibility of radiomics and machine learning for the prediction of prognostic data in breast cancer, encouraging further, preferably multicenter, investigations to further improve the performance of the model and assess its generalizability. ABSTRACT: Aim: To non-invasively predict Oncotype DX recurrence scores (ODXRS) in patients with ER+ HER2- invasive breast cancer (IBC) using dynamic contrast-enhanced (DCE) MRI-derived radiomics features extracted from primary tumor lesions and a ML algorithm. Materials and Methods: Pre-operative DCE-MRI of patients with IBC, no history of neoadjuvant therapy prior to MRI, and for which the ODXRS was available, were retrospectively selected from a public dataset. ODXRS was obtained on histological tumor samples and considered as positive if greater than 16 and 26 in patients aged under and over 50 years, respectively. Tumor lesions were manually annotated by three independent operators on DCE-MRI images through 3D ROIs positioning. Radiomic features were therefore extracted and selected using multistep feature selection process. A logistic regression ML classifier was then employed for the prediction of ODXRS. Results: 248 patients were included, of which 87 with positive ODXRS. 166 (66%) patients were grouped in the training set, while 82 (33%) in the test set. A total of 1288 features was extracted. Of these, 1244 were excluded as 771, 82 and 391 were excluded as not stable (n = 771), not variant (n = 82), and highly intercorrelated (n = 391), respectively. After the use of recursive feature elimination with logistic regression estimator and polynomial transformation, 92 features were finally selected. In the training set, the logistic regression classifier obtained an overall mean accuracy of 60%. In the test set, the accuracy of the ML classifier was 63%, with a sensitivity of 80%, specificity of 43%, and AUC of 66%. Conclusions: Radiomics and ML applied to pre-operative DCE-MRI in patients with IBC showed promises for the non-invasive prediction of ODXRS, aiding in selecting patients who will benefit from NAC. MDPI 2023-03-18 /pmc/articles/PMC10047199/ /pubmed/36980724 http://dx.doi.org/10.3390/cancers15061840 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Romeo, Valeria
Cuocolo, Renato
Sanduzzi, Luca
Carpentiero, Vincenzo
Caruso, Martina
Lama, Beatrice
Garifalos, Dimitri
Stanzione, Arnaldo
Maurea, Simone
Brunetti, Arturo
MRI Radiomics and Machine Learning for the Prediction of Oncotype Dx Recurrence Score in Invasive Breast Cancer
title MRI Radiomics and Machine Learning for the Prediction of Oncotype Dx Recurrence Score in Invasive Breast Cancer
title_full MRI Radiomics and Machine Learning for the Prediction of Oncotype Dx Recurrence Score in Invasive Breast Cancer
title_fullStr MRI Radiomics and Machine Learning for the Prediction of Oncotype Dx Recurrence Score in Invasive Breast Cancer
title_full_unstemmed MRI Radiomics and Machine Learning for the Prediction of Oncotype Dx Recurrence Score in Invasive Breast Cancer
title_short MRI Radiomics and Machine Learning for the Prediction of Oncotype Dx Recurrence Score in Invasive Breast Cancer
title_sort mri radiomics and machine learning for the prediction of oncotype dx recurrence score in invasive breast cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047199/
https://www.ncbi.nlm.nih.gov/pubmed/36980724
http://dx.doi.org/10.3390/cancers15061840
work_keys_str_mv AT romeovaleria mriradiomicsandmachinelearningforthepredictionofoncotypedxrecurrencescoreininvasivebreastcancer
AT cuocolorenato mriradiomicsandmachinelearningforthepredictionofoncotypedxrecurrencescoreininvasivebreastcancer
AT sanduzziluca mriradiomicsandmachinelearningforthepredictionofoncotypedxrecurrencescoreininvasivebreastcancer
AT carpentierovincenzo mriradiomicsandmachinelearningforthepredictionofoncotypedxrecurrencescoreininvasivebreastcancer
AT carusomartina mriradiomicsandmachinelearningforthepredictionofoncotypedxrecurrencescoreininvasivebreastcancer
AT lamabeatrice mriradiomicsandmachinelearningforthepredictionofoncotypedxrecurrencescoreininvasivebreastcancer
AT garifalosdimitri mriradiomicsandmachinelearningforthepredictionofoncotypedxrecurrencescoreininvasivebreastcancer
AT stanzionearnaldo mriradiomicsandmachinelearningforthepredictionofoncotypedxrecurrencescoreininvasivebreastcancer
AT maureasimone mriradiomicsandmachinelearningforthepredictionofoncotypedxrecurrencescoreininvasivebreastcancer
AT brunettiarturo mriradiomicsandmachinelearningforthepredictionofoncotypedxrecurrencescoreininvasivebreastcancer